Lipoic Acid / Niacinamide / Caffeine / Pentoxifylline / Azelaic Acid / Naltrexone / Vitamin D

(Lancapsil-N) Scar Gel

0.5% / 5% / 1.2% / 0.5% / 5% / 0.55% / 10,000 u/gm

Ready to prescribe?
Disclaimer: Images are for reference only; actual products may vary.

Product Overview

This scar gel contains a combination of ingredients that have been included in topical formulations used in scar-related skin care contexts. The formulation brings together components that have been examined in dermatologic literature in relation to skin turnover, pigmentation pathways, and inflammatory processes.

Lipoic Acid1-3

Lipoic acid, also called alpha lipoic acid, may act as an antioxidant and anti-inflammatory agent for the skin. It is believed to help lessen the effects of skin aging or previously damaged skin.

Niacinamide4,5

Niacinamide is a water-soluble form of vitamin B3 that plays an essential role in cellular metabolism. Niacin and niacinamide are both vitamin B3 derivatives with minor structural differences. It has been shown to support the skin barrier and to function as an anti-inflammatory, antioxidant, and skin-brightening agent. When applied topically, niacinamide has been shown to be beneficial for acne vulgaris, melasma, psoriasis, and aging skin.

Caffeine6,7

Caffeine is a xanthine compound that acts as an adenosine-receptor antagonist. It may exhibit antioxidant and anti-inflammatory properties, as well as vasodilatory effects that increase blood flow to wound sites. Caffeine may also help inhibit skin fibrosis and scar formation.

Pentoxifylline8,9

Pentoxifylline may exert anti-inflammatory effects and suppress fibroblast activity. Due to its ability to inhibit fibroblast activity, it may help reduce or prevent the formation of scars and keloids.

Azelaic Acid10

Azelaic acid may have antibacterial, anti-inflammatory, and antioxidant properties. It has been used in dermatology for conditions including rosacea, acne vulgaris, melasma, and the prevention of scar formation.

Naltrexone11-13

Naltrexone is an opioid receptor antagonist that may have anti-inflammatory effects and, at low doses, may be beneficial for certain dermatological indications.

Vitamin D14-16

Vitamin D is a fat-soluble vitamin discovered in the early 1920s and exists primarily as two forms: D2 (ergocalciferol) and D3 (cholecalciferol). It is an essential vitamin that supports bone health, immune function, and the regulation of calcium and phosphorus levels. Vitamin D is inactive in the body and can be obtained through sun exposure, diet, and supplements, requiring activation to exert physiological effects. It may provide immunomodulatory, anti-inflammatory, and antioxidant activity for the skin.kin.

Lipoic Acid1-3

Lipoic acid, as an antioxidant for dermatological properties, may act as a free radical scavenger. It also decreases the deposition of collagen in the skin and may lower glycosaminoglycans which are secreted by fibroblasts. In addition, lipoic acid may decrease pro-inflammatory cytokines and transforming growth factor β1. This activity may work to decrease or minimize scar formation on the skin.

Niacinamide4,5

Niacinamide may inhibit melanosome transfer, increase ceramide synthesis and act as an anti-inflammatory. Specifically, niacinamide is thought to inhibit proteins (sirtuins and poly-(ADP-ribose) polymerases) in the skin and reduce reactive oxygen species to decrease inflammation. Niacinamide may decrease underlying inflammation to decrease hyperpigmentation and hypertrophic changes in a scar.

Caffeine6,7

Caffeine may reduce collagen synthesis and overall fibroblast activity. It also decreases the activity of keratinocytes and interferes with transforming growth factor beta activation.

Pentoxifylline8,9

Pentoxifylline may decrease collagen, fibronectin, and glycosaminoglycan production leading to decreased fibroblast activity in the skin.

Azelaic Acid10

Azelaic acid may decreases the transcription of cytokines and chemokines to decrease blood flow and inflammation in a scar. It also may prevent the generation of reactive oxygen species and decrease oxidative damage.

Naltrexone11-13

Naltrexone may have immunomodulatory activity by decreasing Toll-like receptors signaling, minimizing release of proinflammatory cytokines (tumor necrosis factor, interleukin-6, interleukin- 12), inhibiting T lymphocyte proliferation, and down-regulating the expression of chemokine receptors in the skin. These activities may decrease inflammation and prevent scar formation.

Vitamin D14-16

Vitamin D decreases inflammation in the skin through the inhibition of the production of collagen by inhibiting the formation of fibroblast cells and development of fibrous tissue. It decreases the production of extracellular matrix triggered by TGF-β to facilitate anti-inflammatory activity.

Common1 

  • Erythema, itching and rash

Contraindications1,2 

  • Known hypersensitivity to lipoic acid, niacinamide, caffeine, pentoxifylline, azelaic acid, naltrexone and vitamin D or any excipients

Precautions1,2 

  • Use with other agents that can dry or irritate the skin (retinoids, benzoyl peroxide)

Store at 20°C to 25°C (68°F to 77°F). Protect from light, moisture, and heat.

  1. Nguyen H, Pellegrini MV, Gupta V. Alpha-Lipoic Acid. StatPearls. January 26, 2024. Accessed August 4, 2025.
  2. de Bengy A-F, Decorps J, Martin LS, Pagnon A, Chevalier FP, Sigaudo-Roussel D, Fromy B. Alpha-Lipoic Acid Supplementation Restores Early Age-Related Sensory and Endothelial Dysfunction in the Skin. Biomedicines. 2022; 10(11):2887.
  3. Caikun Liu, Ruilin Lu, Mengqi Jia, Xiao Xiao, Yun Chen, Pengfei Li, and Shiyong Zhang. Biological Glue from Only Lipoic Acid for Scarless Wound Healing by Anti-inflammation and TGF-β Regulation. Chemistry of Materials 2023 35 (6), 2588-2599.
  4. Marques C, Hadjab F, Porcello A, Lourenço K, Scaletta C, Abdel-Sayed P, Hirt-Burri N, Applegate LA, Laurent A. Mechanistic Insights into the Multiple Functions of Niacinamide: Therapeutic Implications and Cosmeceutical Applications in Functional Skincare Products. Antioxidants (Basel). 2024 Mar 30;13(4):425.
  5. Kazemeini S, Nadeem-Tariq A, Luthra A, Suha R, Turna A, Easterly J, Pokharel S, Muqaddas S, Kazemeini M. Evidence-Based Topical Therapy for Facial Scars in Diverse Skin Types. Cureus. 2025 Jun 19;17(6):e86343.
  6. Jiu-Cheng Ma, Zhao-Nan Wang, Ming-Fan Xi, Dong Yin, LI-Fan Jiang, Jun Qi, Experimental Study on the Effect of Caffeine Hydrogel on the Expression of TGF -β1, α-SMA and Collagen in Hypertrophic Scar of Rabbit Ears, Journal of Burn Care & Research, Volume 45, Issue 1, January/February 2024, Pages 85–92.
  7. Zhong Y, Zhang Y, Lu B, Deng Z, Zhang Z, Wang Q, Zhang J. Hydrogel Loaded with Components for Therapeutic Applications in Hypertrophic Scars and Keloids. Int J Nanomedicine. 2024 Jan 25;19:883-899.
  8. Hassan I, Dorjay K, Anwar P. Pentoxifylline and its applications in dermatology. Indian Dermatol Online J. 2014 Oct;5(4):510-6.
  9. Balazic E, Axler E, Konisky H, Khanna U, Kobets K. Pentoxifylline in dermatology. J Cosmet Dermatol. 2023 Feb;22(2):410-417.
  10. Petrovici A-G, Spennato M, Bîtcan I, Péter F, Cotarcă L, Todea A, Ordodi VL. A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations. Pharmaceuticals. 2025; 18(9):1273.
  11. Menta N, Vidal SI, Friedman A. An Update on the Off-Label Uses of Low-Dose Naltrexone in Dermatology. J Drugs Dermatol. 2024 Dec 1;23(12):1127-1128.
  12. Dunn J, Liu Y, Banov F, Denison S, Banov D. A topical naltrexone formulation for surgical wound healing: A case report. Journal of Cosmetic Dermatology 2020.
  13. Sikora M. Rakowska A. Olszewska M, Rudnicka L. The Use of Naltrexone in Dermatology. Current Evidence and Future Directions. Current Drug Targets 2019,20:1058-1067.
  14. Li Q, Chan H. Vitamin D and skin disorders: bridging molecular insights to clinical innovations. Mol Med. 2025 Jul 18;31(1):259.
  15. The Role of Vitamin D in Scar Healing: A Comprehensive Guide – HealFast. https://healfastproducts.com/blogs/posts/the-role-of-vitamin-d-in-scar-healing January 6, 2025. Accessed September 26, 2025.
  16. Hassan AR, Binsaleh AY, El-Tahlawi SM, El-Amir AM, Ishak MM, Alsubaie N, El-Masry TA, Bahaa MM, Eldesoqui M, Kamal M. Impact of Vitamin D Injection on Keloids and Hypertrophic Scars. J Cosmet Dermatol. 2025 Apr;24(4):e70118.

WPPL operates as a 503A compounding pharmacy and prepares individualized prescription medications pursuant to provider direction. Compounded preparations are not reviewed, tested, or approved by the FDA.

This listing also includes commercially manufactured products for convenience; these items are not compounded by our pharmacy and are sold as provided by their manufacturers. Any statements regarding non-compounded products are manufacturer-supplied, have not been evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. WPPL does not verify or endorse any therapeutic claims made by manufacturers. Please refer to original labeling for complete product information.

EXPLORE MORE

Related Medications

Licensed to ship across the U.S.

Your orders arrive promptly and privately, delivered directly to your door.

Providers: Let’s Partner for Better Patient Care

If you are a physician, clinic, or practice seeking a dependable Compounding Pharmacy partner, WP Pharma Labs is here to help. With dedicated account setup, streamlined ordering and responsive service, we support your therapeutic goals with specialized compounds designed for your patients.

To check product availability, check on the status of an existing order, request refills:
orders@wppharmalabs.com

New providers setup / update an existing account:
newaccounts@wppharmalabs.com